+ All Categories
Home > Documents > Vascular system

Vascular system

Date post: 18-Nov-2014
Category:
Upload: rawalpindi-medical-college
View: 1,108 times
Download: 0 times
Share this document with a friend
Description:
patho
Popular Tags:
38
Atherosclerosis Although global, it reaches epidemic proportions in western nations. Major consequences are myocardial infarction, CVA, aortic aneurysms,less important are gangrene of lower extremities, mesenteric complications, sudden cardiac death, chronic IHD and ischemic encephalopathy. In USA, 50 % of all deaths can be attributed to A.S. It is the disease of elastic and muscular arteries. Basic lesion is atheroma: raised focal plaque in the intima composed of lipids along with fibrous covering cap.
Transcript
Page 1: Vascular system

Atherosclerosis

• Although global, it reaches epidemic proportions in western nations.

• Major consequences are myocardial infarction, CVA, aortic aneurysms,less important are gangrene of lower extremities, mesenteric complications, sudden cardiac death, chronic IHD and ischemic encephalopathy.

• In USA, 50 % of all deaths can be attributed to A.S.

• It is the disease of elastic and muscular arteries.

• Basic lesion is atheroma: raised focal plaque in the intima composed of lipids along with fibrous covering cap.

Page 2: Vascular system

Atherosclerosis

• At first the atheromas are sparse, which increase in no with progressive disease and may involve the entire circumference of the vessel encroaching on the lumen as well as tunica media of the vessel.

• In the small arteries the plaques are occlusive causing ischemic injury.

• In large vessels, the plaques are destructive causing weakening and aneurysms, may also rupture which favours thrombosis and embolism.

Page 3: Vascular system

Hyperlipidemia

• Patients with familial hyperlipidemia are most prone.

• Higher the cholesterol, higher the risk especially LDL cholesterol, hypertriglyceridemia with VLDL.

• Treatment with diet and cholesterol lowering drugs significantly decrease cardiovascular mortality.

• HDL cholesterol reduce the risk.

• High dietary intake of cholesterol raises the plasma levels of cholesterol.

• Paradoxically in Finland, the Eskimos, in spite of high fat intake, incidence of IHD is low because of a specific FA in fish and fish oil, that decreases LDL, increases HDL, and.

Page 4: Vascular system

• And modifies various mediators favoring platelet aggregates.

Page 5: Vascular system

Hypertension

• Mechanism of role in atherosclerosis in unknown. Higher the chronic hypertension, higher the risk of IHD and CVA.

Page 6: Vascular system

Smoking• One of the established risk factor in the incidence and

severity of atherosclerosis.>10-20 cigarettes/day for many years increases risk to >200%. Cessation of smoking reverts the risk.

• Diabetes: diabetics have two fold increased risk of dying from MI, CVA and up to 100 times increased tendency of lower extremity gangrene.

• Other rare risk factors include elevated homocysteine levels causing endothelial dysfunction, raised levels of plasminogen activator inhibitors and inflammation such as plasma fibrinogen and CRP.

Page 7: Vascular system

Morphological Features• The key process is intimal thickening and lipid

accumulation. Fatty streaks appear in young children which are the possible precursors of atheromas.

• Atheromas are the raised focal plaques which consist of cholesterol and esters surrounded by fibrous cap.

• Grossly appear white to yellow, measuring 0.3-1.5 cm, encroach on to lumen, may coalesce to form large lesions.

• Superficial part is firm white, deep soft and yellow.• Distribution: Abdominal aorta, thoracic aorta, more often

near ostia of major branches; coronary, popliteal, circle of Willis; upper limbs, renal and mesenteric vessels spared. Usually patchy and part of circumference is involved.

Page 8: Vascular system

• 3 parts of plaque are smooth muscle cells, macrophages and other inflammatory cells, extracellular matrix e.g. collagen, elastic tissue and proteoglycans, intracellular and extracellular lipid deposits.

• Fibrous cap consists of smooth muscle cells, dense connective tissue, cellular area consists of macrophages and muscle cells, T lymphocytes, deep necrotic core contains lipid material, fibrinous material and other plasma proteins, foamy macrophages which may be transformed macrophages and smooth muscle cells.

• Around the plaque there is neovascularization.• Non atheromatous intimal thickening in coronary arteries

may be due to hemodynamic stress in adults having no significance.

• In late stages, atheromas may get converted to fibrous scar.

Page 9: Vascular system

Complicated Atheromas• Calcification, vessel may be like a brittle pipe.

• Focal rupture and ulceration causing thrombosis and cholesterol emboli.

• Hemorrhage in to the atheromas especially in coronaries.

• Superimposed thrombosis and organization.

• May cause atrophy of underlying media, weakening and aneurysmal dilatation.

Page 10: Vascular system

Fatty Streaks• Not raised, no flow disturbances, precursors of

atherosclerosis.• Begin as small yellow spots, may coalesce to form 1 cm

lesions, composed of foamy macrophages, lymphocytes and minimum amount of lipids.

• Start at 1 year age, most of 10 years aged children have aortic lesions.

• No relation with sex, geography, race and environment.• Distribution same as atherosclerosis.• Not all the streaks develop the ominous disease.• Types of atheromatous lesions: isolated foam cells, fatty

streaks, small extracellular lipid collections, fibrofatty atheroma and complicated lesions.

Page 11: Vascular system

Pathogenesis of Atherosclerosis• Its clinical implications are grave consequences has stimulated the

scientists to explore and discover the cause.• Hypothesis 1: cellular proliferation in intima as a reaction to

insudation of plasma proteins and lipids. Organization and repetitive growth of thrombi result in plaque formation.

• Current theory: it is a chronic inflammatory response of the arterial wall initiated by some form of injury to the endothelium.

• 1- chronic focal endothelial injury- dysfunction- increased permeability and leukocyte adhesion.

• 2- lipoprotein insudation asp LDL, VLDL, their oxidation.• 3- adhesion of monocytes, transformation to foamy macrophages• 4- platelet adhesion• 5- activated platelets and macrophage release factors that cause

migration of smooth muscle cells from media.

Page 12: Vascular system

• 6- smooth muscle proliferation in intima, elaboration of extracellular matrix leading to accumulation of collagen and proteoglycans.

• 7- accumulation of intracellular and extracellular lipids.

Page 13: Vascular system

Endothelial Injury• Human lesion develop in intact endothelium, so

endothelial dysfunction and activation are more important in causing permeability, leukocyte adhesion and alterations, in expression of a number of endothelial gene products which mediate adhesion of monocyte and lymphocytes.

• Endothelial dysfunction may be due to endotoxins, hypoxia, products of cigarette smoking, homocysteine and viruses.

• Currently it is postulated that hemodynamic disturbances (ostia and posterior aortic wall, which are adversely affected by shear stress) and adverse effects of hypercholesterolemia are the main factors in endothelial injury.

Page 14: Vascular system

Role of Lipids• Increased lipids cause endothelial dysfunction through

superoxide and other oxygen free radicals that deactivate NO.

• Increased lipids result in lipoproteins accumulation in intima.

• Lipid oxidation yields oxidized LDL ingested readily by macrophages to form foam cells which is chemotactic for monocytes and increased their adhesion. It inhibits macrophage mobility favoring retention. It stimulates release of growth factors and cytokines. It is cytotoxic to endothelial cells and smooth muscle cells. It is immunogenic with formation of antibodies to lipoproteins.

Page 15: Vascular system

Role of Macrophages• Monocytes adhere to endothelium, proliferate and migrate to

subendothelial tissues, change to macrophages, engulf lipoproteins esp. oxidized LDL, transform to foamy macrophages.

• Macrophages have secretory and biological functions via IL-1, TNF which cause adhesion of leukocytes and monocytes, chemoattractant proteins, produce toxic oxygen species that cause smooth muscle proliferation, T lymphocytes are also present by unknown mechanism.

• As long as hypercholesterolemia persists, monocyte adhesion, subendothelial migration of smooth muscle cells and accumulation of lipids within macrophages and smooth muscle cells continues eventually leading to form fatty streaks. May regress if hypercholesterolemia is ameliorated.

Page 16: Vascular system

Role of Smooth Muscle Cell Proliferation

• If hypercholesterolemia persists, smooth muscle proliferation and extracellular matrix deposition, in intima continues, which is one of the major factors converting streaks in to atheromas.

• Growth factors implicated in vascular smooth muscle cell proliferation are: PDGF (Platelets, macrophages, endothelial cells, smooth muscle cells), FGF and TGF-alpha.

• inhibitors are heparin like molecules, TGF-beta.

Page 17: Vascular system

Progression of Lesions• Initial intimal plaque: central aggregates of foamy

macrophages and foamy smooth muscle cells.

• If progression occurs, cellular fatty atheroma is modified by further deposition of collagen and proteoglycans. Some plaques may be fibrous by increased connective tissue.

• Many of the atheromas undergo disruption and thrombosis which may be associated with catastrophic consequences.

Page 18: Vascular system

Clinical Features and Prevention• May be due to thrombosis, calcification, aneurysmal

dilatations, distal ischemic events in heart, brain and lower extremities.

• So measures to prevent the toll are both primary and secondary.

• Primary are meant to delay the atheroma formation and regression. Smoking, hypertension, weight, exercise, alcohol, lowering of LDL and increasing HDL.

• Secondary to prevent recurrences of serious events. Decreased lipids and anti platelet drugs.

Page 19: Vascular system

Normal Aorta with no Fatty Streaks

Page 20: Vascular system

Fatty Streaks

Page 21: Vascular system

Fatty Streaks, Coronary Artery with Increased Fat

Page 22: Vascular system

Coronary Artery Atherosclerosis with Thrombosis and Narrowing

Page 23: Vascular system

Normal Coronary Artery

Page 24: Vascular system

Coronary Artery Atherosclerosis

Page 25: Vascular system

Coronary Atherosclerosis with Thrombosis and Cholesterol Clefts

Page 26: Vascular system

Atheroma, Showing Foamy Macrophages and Cholesterol Clefts.

Page 27: Vascular system

Atheroma with Calcification

Page 28: Vascular system

Aortic Atherosclerosis

Page 29: Vascular system

Aortic Atherosclerosis, Mild, Moderate, Severe

Page 30: Vascular system

Atherosclerosis with Hemorrhage and Cholesterol Clefts, Aorta

Page 31: Vascular system

Cholesterol Clefts, HP

Page 32: Vascular system

Hypertensive Vascular Disease

• It affects both structure and function of small muscular arteries and arterioles.

• It has devastating consequences and remains asymptomatic for long periods.

• One of the major risk factor for heart disease, CVA, cardiac hypertrophy with failure, aortic dissections and renal failure esp. if systolic blood pressure is sustained above 140 mm and diastolic more than 90 mm.

• Prevalence is more with increasing age, blacks are affected twice more often, more vulnerable to complications.

Page 33: Vascular system

Causes • In 90% primary.

• Secondary: Renal.Ac Glomerulonephritis.

Ch Renal Disease.

Renal Artery Stenosis and Vasculitis.

Renin producing Tumours.

Endocrine.Cushing Syndrome.

Primary Aldosteronism.

Exogenous Hormones.

Sympathomimetic Drugs.

MAO inhibitors.

Phaeochromocytoma.

Acromegaly.

Page 34: Vascular system

Causes• Cardiovascular.• Coarctation of Aorta.

• Increased Blood Volume.

• Aortic Rigidity.

• Neurologic.• Increased Intracranial Pressure.

• Acute Stress, Operative Procedures.

Page 35: Vascular system

• Accelerated Hypertension: >120 mm diastolic, if untreated, death occurs within 1-2 years.

• Complications include: renal failure, retinal hemorrhage, exudates and papilloedema.

Page 36: Vascular system

Regulation of Blood Pressure• Cardiac Out Put x Peripheral Resistance.

• Cardiac Out Put: Blood volume (Na, Mineralocorticoids, Atrial Natriuretic Peptides, Heart rate, Contractility).

• Peripheral Resistance: Humoral constrictors (Angio II, Catecholamines, Thromboxane, Leucotrienes, Endothelin).

• Humoral Dilators: Prostaglandins, Kinins, NO/ EDRF.

• Peripheral Resistance: Local Autoregulation by pH and Hypoxia; Neural Regulation is by alpha adrenergic drugs.

Page 37: Vascular system

Pathogenesis of Hypertension• Changes that alter the relationship between blood volume

and resistance.• Mechanism of development: (1)• Genetic factors: Twins, Family History (Mostly Polygenic

and heterogeneous disorder).• Environmental: Chinese in China have low BP, Stress,

Obesity, Physical Inactivity, increased salt intake.• Mechanism of development: (2)• Renal retention of excess Na, increased volume, increased

cardiac output, vasoconstriction to prevent over perfusion of tissues. At increased BP, kidneys cab excrete more Na, called reseting of pressure natriuresis.

Page 38: Vascular system

• Second hypothesis suggests increased resistance as primary event; factors may be functional vasoconstriction by increased sensitivity to vasoconstrictors due to genetic defect in transport of Na and Ca, Neurogenic release of vasoconstrictors.

• Structural changes in vessel walls causing thickened walls and narrowed lumina.


Recommended